Evidence map›Paper›PMID 38713692›Full record

ArticlePloS one2024

Multicriteria decision making attributes and estimation of physicochemical properties of kidney cancer drugs via topological descriptors.

Mohamad Nazri Husin, Abdul Rauf Khan, Nadeem Ul Hassan Awan, Francis Joseph H Campena, Fairouz Tchier, Shahid Hussain

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Predictive modelling and ranking:Frontiers in chemistry · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Mohamad Nazri HusinSpecial Interest Group on Modeling and Data Analytics, Faculty of Computer Science and Mathematics, Universiti Malaysia Terengganu, Nerus, Terengganu, Malaysia.
Abdul Rauf KhanDepartment of Mathematics, Faculty of Sciences, Ghazi University, Dera Ghazi Khan, Pakistan.ORCID 0000-0002-4709-3860
Nadeem Ul Hassan AwanDepartment of Mathematics, Faculty of Sciences, Ghazi University, Dera Ghazi Khan, Pakistan.ORCID 0000-0002-3973-703X
Francis Joseph H CampenaDepartment of Mathematics and Statistics, De La Salle University, Malate Manila, Metro Manila, Philippines.ORCID 0000-0002-6037-6769
Fairouz TchierMathematics Department, College of Science, King Saud University, Riyadh, Saudi Arabia.ORCID 0000-0001-7855-508X
Shahid HussainEnergy Engineering Division, Department of Engineering Science and Mathematics, Lulea University of Technology, Lulea, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Based on topological descriptors, QSPR analysis is an incredibly helpful statistical method for examining many physical and chemical properties of compounds without demanding costly and time-consuming laboratory tests. Firstly, we discuss and provide research on kidney cancer drugs using topological indices and done partition of the edges of kidney cancer drugs which are based on the degree. Secondly, we examine the attributes of nineteen drugs casodex, eligard, mitoxanrone, rubraca, and zoladex, etc and among others, using linear QSPR model. The study in the article not only demonstrates a good correlation between TIs and physical characteristics with the QSPR model being the most suitable for predicting complexity, enthalpy, molar refractivity, and other factors and a best-fit model is attained in this study. This theoretical approach might benefit chemists and professionals in the pharmaceutical industry to forecast the characteristics of kidney cancer therapies. This leads towards new opportunities to paved the way for drug discovery and the formation of efficient and suitable treatment options in therapeutic targeting. We also employed multicriteria decision making techniques like COPRAS and PROMETHEE-II for ranking of said disease treatment drugs and physicochemical characteristics.

Indexed as

Antineoplastic AgentsKidney NeoplasmsQuantitative Structure-Activity RelationshipDecision MakingDrug DiscoveryHumansAntineoplastic Agents

Identifiers

PMID38713692
PMCPMC11075897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.